Skip to Content

RPR 202 (Rilutek 50 mg)

Generic Name: riluzole

Pill with imprint RPR 202 is White, Elliptical / Oval and has been identified as Rilutek 50 mg. It is supplied by Aventis Pharmaceuticals.

Rilutek is used in the treatment of amyotrophic lateral sclerosis and belongs to the drug class miscellaneous central nervous system agents. Risk cannot be ruled out during pregnancy. Rilutek 50 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for RPR 202

Rilutek 50 mg RPR 202
Rilutek 50 mg RPR 202
Rilutek 50 mg RPR 202


Generic Name:
RPR 202
50 mg
10.00 mm
Elliptical / Oval
Prescription only
Drug Class:
Miscellaneous central nervous system agents
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Aventis Pharmaceuticals
Inactive Ingredients:
calcium phosphate dibasic anhydrous
microcrystalline cellulose
silicon dioxide
magnesium stearate
croscarmellose sodium
polyethylene glycol 6000
titanium dioxide
Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2018, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.